P1.193. Neoadjuvant Therapies vs Upfront Surgery for cT2N0 Oesophageal Cancer – a Systematic Review and Meta-Analysis
Esophageal Cancer: Surgical Treatment of Esophageal Cancer In March 2026, the International Society for Diseases of the Esophagus (ISDE) made ‘conditional’ recommendations in support of neoadjuvant therapy (NAT) over primary surgical resection (PSR) for patients diagnosed with cT2N0 oesophageal cancer. Not...